产品介绍
Product Description
Application
MEGX has been used in an approach to improve the yield of N-dealkylated lidocaine.
Biochem/physiol Actions
MEGX is generated by hepatic cytochrome P-450 system upon oxidative de-ethylation. Measurement of MEGX by immunoassay contributes to liver function test. MEGX possesses antiarrhythmic action and therefore extends lidocaine effect.
Lidocaine metabolite
Monoethylglycinexylidide (MEGX) is an active metabolite of lidocaine.
技术参数
Specifications
| Quality Segment | 100 |
| assay | ≥95% (HPLC) |
| form | powder |
| storage condition | desiccated |
| color | white to beige |
| solubility | H2O: 10 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | CC1=C(NC(CNCC)=O)C(C)=CC=C1 |
| InChI | 1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15) |
| InChI key | WRMRXPASUROZGT-UHFFFAOYSA-N |
